Download full-text PDF |
Source |
|---|
Publication Analysis
Top Keywords
Similar Publications
Bladder cancer: a retrospective audit at a single radiation oncology unit of an academic hospital in Johannesburg, South Africa.
J Egypt Natl Canc Inst
November 2024
University of the Witwatersrand, Faculty of Health Sciences, School of Clinical Medicine, Department of Radiation Sciences, Division of Radiation Oncology, University of the Witwatersrand, Faculty of Health Sciences, School of Clinical Medicine, Department of Radiation Sciences, Division of Radiation Oncology, Johannesburg, South Africa.
Background: Bladder cancer (BCa) is one of the most common urological cancers and remains a leading cause of cancer-related mortality worldwide. Bladder cancer is associated with a range of risk factors, with smoking being one of the most significant contributors. In addition to smoking, exposure to certain chemicals, particularly aromatic amines found in industries such as dye, rubber, leather, and textiles, also increases the risk of bladder cancer.
View Article and Find Full Text PDFOvarian cancer red flags: help prevent delayed diagnosis.
Br J Nurs
March 2024
GP practising in Northamptonshire and Primary Care Advisory Board member, Target Ovarian Cancer.
Ovarian cancer is classified as a gynaecological cancer, but the symptoms present as abdominal and they can be mistaken for those of a bowel condition or bladder problems. Target Ovarian Cancer is urging clinicians to recognise the red flags for ovarian cancer, and to never diagnose new-onset irritable bowel syndrome (IBS) or overactive bladder in women over 50 without ruling out ovarian cancer. The symptoms of these are also red flags for ovarian cancer and warrant further investigations.
View Article and Find Full Text PDFReliability, validity, and change thresholds of the NCCN/FACT Bladder Symptom Index (NFBlSI-18) in patients with advanced urothelial cancer.
Cancer
January 2024
Department of Medical Social Sciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.
Background: The NCCN/FACT Bladder Symptom Index-18 (NFBlSI-18) is a bladder cancer-specific instrument. We aimed to psychometrically evaluate the reliability and validity of NFBlSI-18 and estimate change thresholds for total, disease-related symptoms-physical (DRS-P), DRS-emotional (DRS-E), and function/well-being (F/WB) scales in patients with locally advanced/metastatic urothelial cancer (la/mUC).
Methods: JAVELIN Bladder 100 trial data were analyzed.
An Analysis of Google Trends During COVID-19: Determining Public Urological Cancer Concerns.
Cureus
November 2022
Department of Urology, State University of New York (SUNY) Downstate Health Sciences University, Brooklyn, USA.
Background The COVID-19 pandemic put a massive strain on the healthcare system as patients avoided the hospital, elective cases were postponed, and general medical anxiety was increased. We aimed to capture public interest in urological cancers during this massive shock to the medical field. Methodology A total of 12 keywords related to the three most prevalent urological cancers (prostate, bladder, and kidney) were searched using Google Trends from 2018 to 2022.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!